EQS-News: ABIVAX / Key word(s): PersonnelAbivax appoints Dr. Sheldon Sloan, M.D., as Chief Medical Officer 17.02.2023 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Abivax appoints Dr. Sheldon Sloan, M.D., as Chief Medical OfficerSheldon Sloan, M.D., M. Bioethics, has a strong.
Sheldon Sloan, M.D., M. Bioethics, has a strong track record in product development and commercial launches in the pharmaceutical industry with a focus on Inflammatory Bowel DiseaseAs CMO of Abivax, Dr.